Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2923 of 5804
-
Smart drug schedule may improve melanoma treatment
Disease control OngoingThis pilot early phase I trial studies how well encorafenib, binimetinib, and nivolumab work in treating patients with BRAF mutant stage IIIC-IV melanoma. Encorafenib and binimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immuno…
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug TG02 shows promise in early brain cancer trial
Disease control CompletedThis is a three parallel cohort, open-labeled, non-randomized, multicenter study. All three cohorts will enroll independently.
Phase: PHASE1 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Hidden danger: muscle disease linked to deadly clots
Knowledge-focused CompletedInvestigators identified a high risk of deep vein thrombosis and pulmonary embolism in patients presenting myotonic dystrophy type 1 treated in our hospital, 10 times higher than general population matched on age and sex. These venous thromboembolic events were frequently severe …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:53 UTC
-
Short exercise program boosts quality of life in breast cancer survivors
Symptom relief CompletedBreast cancer (BC) is one of the most common cancers among women worldwide, with survival rates steadily improving due to advances in early detection and treatment. Despite these improvements, survivors frequently experience long-term side effects such as fatigue, reduced physica…
Phase: NA • Sponsor: Universidad de Burgos • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Blood test may predict Crohn's drug success
Knowledge-focused CompletedThe overall goal of the study is to develop data that can convincingly guide clinicians on the use and efficacy of vedolizumab in patients with small bowel CD. There is an unmet need to identify response to vedolizumab in small bowel CD using objective endpoints. Current data sug…
Phase: PHASE4 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:17 UTC
-
Can farming plus nutrition help stop child stunting? kenya study finds out.
Knowledge-focused CompletedMalnutrition is a public health problem in Kenya, with 26% of children underfive years of age stunted, and 26% of pre-school children, 26% of women of reproductive age and 42% of pregnant women being anaemic, respectively. Agriculture is the main source of income, food and nutrie…
Phase: NA • Sponsor: Fabian Rohner • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
New drug combo shows promise for tough bladder cancer
Disease control CompletedBackground: Non-muscle-invasive bladder cancer is in the early stages. But it usually comes back after treatment. The drugs Vicineum and Durvalumab may help the immune system find and destroy cancer cells. Objective: To test if the drugs Durvalumab and Vicineum together are sa…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New ultrasound wand could spot mouth cancer without a knife
Diagnosis Recruiting nowOral diseases are currently diagnosed by means of clinical examination and supported by surgical biopsy procedures. In particular, daily oral medicine practice is lacking the use of a routine diagnostic support to the visualization of anatomical structures located beyond the muco…
Phase: NA • Sponsor: University of Pisa • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Blood biomarkers may let ICU patients stop antifungals earlier
Disease control CompletedEmpirical antifungal therapy (EAT) is frequently prescribed to septic critically ill patients with risk factors for invasive Candida infections (ICI). However, among patients without subsequent proven ICI, antifungal discontinuation is rarely performed, resulting in unnecessary a…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug runimotamab takes on Hard-to-Treat HER2 cancers
Disease control OngoingThis study will evaluate the safety, tolerability, and pharmacokinetics of Runimotamab administered intravenously as a single agent and in combination with Trastuzumab in participants with locally advanced or metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-expressing c…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Virtual reality tested as pain relief for burn patients
Symptom relief Recruiting nowThis study is a randomized proof-of-concept study to assess the efficacy of Virtual Reality (VR) vs standard of care in 50 adult patients in the New York Presbyterian Burn Unit. The participants who are randomized to receive the virtual reality intervention will also receive opio…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Brain training games show promise for schizophrenia vision problems
Symptom relief CompletedThe purpose of this study is to evaluate the effectiveness of a visual remediation intervention for people with schizophrenia. The intervention targets two visual functions that much research has shown are impaired in many people with the disorder, namely contrast sensitivity and…
Phase: NA • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jun 26, 2026 13:24 UTC
-
Experimental drug voruciclib tested in desperate blood cancer patients
Disease control TerminatedThis is a Phase 1, open-label, dose escalation study to determine the safety and preliminary efficacy of voruciclib monotherapy in subjects with relapsed/refractory B cell malignancies or AML after failure of standard therapies or voruciclib in combination with venetoclax in subj…
Phase: PHASE1 • Sponsor: MEI Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Web therapy for addiction shows promise in native communities
Disease control CompletedThe purpose of the current study is to evaluate the preliminary efficacy of the Therapeutic Education System-Native Version (TES-NAV) (an efficacious web-delivered psychosocial intervention for substance use disorders adapted with American Indians/Alaska Natives \[AI/AN\]) to det…
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could tight clothing and dance help EDS patients regain balance?
Symptom relief CompletedIn the absence of a medical consensus, the current management of Ehlers-Danlos Syndrome hypermobility type (hEDS) remains very speculative That's why investigators want in this study to demonstrate the beneficial contribution of an innovative therapeutic strategy combining reprog…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
A simple letter could ease grief for caregivers after a loved One's death
Symptom relief CompletedThe aim of this randomized multicenter study is to evaluate the impact in offering the condolence letter to the family caregivers (indicated as the reliable person by the patient himself at each hospitalization) and a bereavement consultation with the reference physician.
Sponsor: Institut Paoli-Calmettes • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Hospital push could shield seniors from preventable diseases
Prevention CompletedIn France, vaccination coverage is insufficient (in 2002, 71.2% coverage for tetanus, 41.9% for poliomyelitis and 33.7% for diphteria). These numbers decrease significantly with age: coverage for people aged over 65 was 60.5%, 13.3% and 10.5% for tetanus, poliomyelitis and diphte…
Phase: NA • Sponsor: Centre Hospitalier le Mans • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
New drug combo aims to stop breast cancer return after failed chemo
Disease control CompletedThe purpose of this study is to test the safety of a study drug called Rucaparib, administered in combination with the type of radiation therapy that is usually given to women with your form of breast cancer.
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New cancer drug MRX-2843 enters first human trial
Disease control CompletedThis first-in-human open-label, dose escalation study is designed to evaluate the safety, tolerability, and PK of MRX-2843 in subjects with relapsed/refractory advanced and/or metastatic solid tumors.
Phase: PHASE1 • Sponsor: Meryx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Experimental t cell therapy targets sarcoma in small early trial
Disease control CompletedThe main purpose of this trial is to investigate the safety and tolerability of NY-ESO-1(TCR Affinity Enhancing Specific T cell Therapy)in the first-line treatment failed advanced bone and soft tissue sarcoma. The secondary purpose of this trial is to investigate the efficacy of …
Phase: PHASE1 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC